Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 732 results found. Search for [ Indian pharma companies in US ]

Results 60 to 80 of 732
BusinessToday.In
January 14, 2019
The investment is said to be part of a larger $100 million investment that the Flipkart co-founder has committed to Ola


PTI
January 8, 2019



E Kumar Sharma
January 4, 2019
Analysts believe hopefully the tide may turn this year and some of the leading companies like Dr Reddy's that are still facing regulatory challenges may get some relief.


PTI
December 31, 2018



PTI
December 31, 2018
Industry players expect more partnerships in the new year between public and the private sector in the healthcare space, which they feel is 'under-invested'


PTI
December 31, 2018



BusinessToday.In
New Delhi, December 28, 2018
Since hitting an all-time high of Rs 84.06 on October 3, fuel prices has been on a downward trajectory due to consistent fall in Brent crude prices and appreciation of rupee against US dollar.


PTI
December 24, 2018



PTI
December 21, 2018



BusinessToday.In
New Delhi, December 20, 2018
BEML shares gained over 30 per cent in the last 10 sessions after the company bagged a contract worth about Rs 3,015 crore from DMRC for supply of 378 metro coaches (63 metro trains) to Mumbai Metro Line - 2 & 7 project.


E Kumar Sharma
New Delhi, December 18, 2018
Leading Indian pharma company Dr Reddy's has still not been able to overcome the regulatory challenges. Its important Duvvada facility in Andhra has been under warning letter from the US drug regulator since 2015.


PTI
December 18, 2018



PTI
December 18, 2018



PTI
December 13, 2018



BusinessToday.In
new Delhi, December 11, 2018
The BSE SENSEX closed at 35,150.01, up by 190.29 points, or by 0.54 per cent and the NSE Nifty ended higher by 60.70 points, or 0.58 per cent, at 10,549.15.


PTI
December 7, 2018



PTI
November 27, 2018



PTI
November 26, 2018



PB Jayakumar
New Delhi, November 26, 2018
Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.


E Kumar Sharma
New Delhi, November 26, 2018
Teva, Mylan, and even India's biggest, Sun Pharma, are opting out of products that aren't commercially viable.


PAGES 4 OF 37  12345